U.S. Army Medical Research Institute of Infectious Diseases

USAMRIID is the Department of War's premier institute for bio-terror threat mitigation and infectious disease research. It plays a critical role in developing vaccines, therapeutics, and diagnostics to combat deadly pathogens such as anthrax, Ebola, and Marburg virus. USAMRIID's novel antibody discovery platform has led to groundbreaking monoclonal antibody-based therapies for hemorrhagic fever viruses and encephalitic viruses. Its work ensures that Warfighters are protected against biological threats, both natural and man-made, while advancing global health security.